Gamma camera developer GVI Medical Devices of Twinsburg, OH, promoted its OnePass gamma camera for first-pass nuclear cardiology studies in its Society of Nuclear Medicine (SNM) booth.
GVI was founded by former executives from nuclear medicine firm SMV after that company was purchased by GE Healthcare in 2000. Leading the firm is Randy Sommerdyke, who was president of SMV at the time of the GE acquisition.
GVI saw the need for a dedicated first-pass nuclear cardiology system following the demise of Scinticor in the 1990s, Sommerdyke said. GVI introduced the OnePass gamma camera two years ago to fill that need with a system that enables users to acquire ejection fractions with first-pass cardiac studies at very high count rates while patients are at full exercise.
OnePass collects 400,000 count rates per second using 3/8-inch sodium iodide crystals set in 8.5 x 8.5-inch detectors. The system carries a list price of about $200,000.
Its unique features include the ability to automatically start the system with the bolus injection of radiopharmaceutical, and the ability of the detector to move with patients as they exercise for more accurate imaging.
 |
| GVI's OnePass camera is designed to fill a niche in cardiac imaging. |
As a work-in-progress, GVI also demonstrated StatCam, a non-SPECT gamma camera for planar and resting first-pass imaging. Sommerdyke said the goal of StatCam is to replace the void left by major multimodality OEMs that have stopped manufacturing mobile gamma cameras. The system could be used in bedside environments, emergency rooms, surgical suites, and anywhere a backup is needed for non-SPECT imaging applications.
GVI expects to receive 510(k) clearance from the U.S. Food and Drug Administration and start shipping StatCam by the end of 2006.
By AuntMinnie.com staff writers
June 7, 2006
Copyright © 2006 AuntMinnie.com
